Capricor Therapeutics Ownership | Who Owns Capricor Therapeutics?


OverviewForecastFinancialsChartTranscripts

Capricor Therapeutics Ownership Summary


Capricor Therapeutics is owned by 26.23% institutional investors, 16.80% insiders, and 56.97% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.24% of CAPR shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.69% of its assets in Capricor Therapeutics shares.

CAPR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCapricor Therapeutics26.23%16.80%56.97%
SectorHealthcare Stocks 231.98%10.74%-142.72%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de2.85M6.24%$82.28M
Vanguard group2.56M5.60%$73.94M
Blackrock1.63M5.19%$7.77M
Geode capital management1.02M2.23%$29.37M
State street801.34K1.75%$5.78M
Soleus capital management646.39K1.41%$18.65M
Morgan stanley585.84K1.28%$16.91M
J. goldman & co lp481.98K1.05%$3.48M
Dg capital management470.33K1.03%$3.39M
Goldman sachs group447.98K0.98%$12.93M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dg capital management470.33K1.18%$3.39M
Moody aldrich partners208.75K1.12%$6.02M
Soleus capital management646.39K0.69%$18.65M
Black diamond financial79.08K0.24%$2.28M
Seven grand managers100.00K0.22%$2.89M
Ikarian capital264.64K0.19%$1.91M
Ellerson group inc /adv9.69K0.19%$279.65K
Stoneridge investment partners8.46K0.17%$244.00K
Hbk sorce advisory203.71K0.12%$5.04M
J. goldman & co lp481.98K0.09%$3.48M

Top Buyers

HolderShares% AssetsChange
Blackrock1.63M0.00%1.25M
Soleus capital management646.39K0.69%646.39K
J. goldman & co lp481.98K0.09%481.98K
Dg capital management470.33K1.18%470.33K
Vanguard group2.56M0.00%355.16K

Top Sellers

HolderShares% AssetsChange
Altium capital management lp---714.00K
State street801.34K0.00%-665.34K
Pier capital---496.55K
Octagon capital advisors lp---450.00K
Superstring capital management lp---241.19K

New Positions

HolderShares% AssetsChangeValue
Soleus capital management646.39K0.69%646.39K$18.65M
J. goldman & co lp481.98K0.09%481.98K$3.48M
Dg capital management470.33K1.18%470.33K$3.39M
Ikarian capital264.64K0.19%264.64K$1.91M
Moody aldrich partners208.75K1.12%208.75K$6.02M

Sold Out

HolderChange
Aquatic capital management-1.00
True wealth design-5.00
Northwestern mutual wealth management-19.00
Eversource wealth advisors-35.00
C m bidwell & associates-43.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202573-47.86%11,993,578-17.25%262.61%45-30.77%24-33.33%
Sep 30, 2025136-14,466,2445.28%313.50%62-6.06%36-7.69%
Jun 30, 2025132-7.04%13,682,657-27.15%291.77%63-24.10%4037.93%
Mar 31, 202510-92.48%930,147-94.63%20.08%7-92.39%2-86.67%
Dec 31, 202440-57.45%6,498,502-22.35%193.07%32-42.86%3-72.73%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.46M2.69%-
Vanguard US Total Market Shares ETF872.18K1.91%-
iShares Russell 2000 ETF933.05K1.72%933.05K
SPDR® S&P Biotech ETF584.18K1.28%1.30K
Vanguard Institutional Extnd Mkt Idx Tr496.86K0.91%-1.41K
Fidelity Small Cap Index395.43K0.73%3.87K
Fidelity Select Pharmaceuticals Port389.90K0.72%389.90K
iShares Russell 2000 Growth ETF321.32K0.59%321.32K
Fidelity Select Biotechnology314.70K0.58%314.70K
State St Russell Sm/Mid Cp® Indx NL Cl C227.13K0.50%1.15K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 20, 2024Nippon Shinyaku Co Ltd-Buy$15.00M
Oct 12, 2023Musket David B-Buy$1.13K
Oct 10, 2023COLLIER EARL M JR-Buy$28.30K
Oct 09, 2023Musket David B-Buy$14.33K
Oct 06, 2023Auwaerter Paul Gisbert-Buy$14.20K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q1--
2024 Q4--
2024 Q31-

CAPR Ownership FAQ


Who Owns Capricor Therapeutics?

Capricor Therapeutics shareholders are primarily institutional investors at 26.23%, followed by 16.80% insiders and 56.97% retail investors. The average institutional ownership in Capricor Therapeutics's industry, Biotech Stocks , is 381.47%, which Capricor Therapeutics falls below.

Who owns the most shares of Capricor Therapeutics?

Capricor Therapeutics’s largest shareholders are Blackrock funding, inc. /de (2.85M shares, 6.24%), Vanguard group (2.56M shares, 5.60%), and Blackrock (1.63M shares, 5.19%). Together, they hold 17.03% of Capricor Therapeutics’s total shares outstanding.

Does Blackrock own Capricor Therapeutics?

Yes, BlackRock owns 5.19% of Capricor Therapeutics, totaling 1.63M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.77M$. In the last quarter, BlackRock increased its holdings by 1.25M shares, a 326.62% change.

Who is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested?

Dg capital management is Capricor Therapeutics’s biggest shareholder by percentage of total assets invested, with 1.18% of its assets in 470.33K Capricor Therapeutics shares, valued at 3.39M$.

Who is the top mutual fund holder of Capricor Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Capricor Therapeutics shares, with 2.69% of its total shares outstanding invested in 1.46M Capricor Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools